期刊文献+

CT引导下经皮射频消融治疗较大原发性肝癌的临床应用 被引量:10

Clinical application of CT-guided percutaneous radiofrequency ablation for the treatment of larger hepatocellular carcinomas
下载PDF
导出
摘要 目的探讨CT引导下经皮射频消融(RFA)治疗较大原发性肝癌的疗效。方法对27例TACE治疗效果欠佳的较大原发性肝癌患者行CT引导下经皮RFA治疗,肿瘤大小5.4~11.0 cm,平均6.2 cm,单发病灶23例,2个病灶4例,共31个病灶。AFP阳性22例。术后通过增强CT及AFP检测评价疗效,所有病例随访2~20个月。结果射频治疗后1个月随访显示,31个肿瘤中14个(45.2%)肿瘤完全坏死,内部及边缘无明显强化;17个肿瘤部分坏死。22例AFP阳性患者,AFP明显降低15例(68.2%),不变3例(13.6%),升高4例(18.2%)。并发症中3例出现表皮烫伤,1例顽固性呃逆,1例肝内出血,1例肝脓肿,1例术后出现严重低蛋白血症,术后2个月死亡。患者中位生存期为9.8个月,1年累计生存率29%。结论对于不可切除的较大原发性肝癌,RFA是较有效的局部介入治疗方法,合理应用RFA治疗,可提高患者生活质量并延长患者的生存时间。 Objective To investigate the therapeutic efficacy of CT-guided percutaneous radiofrequency ablation (RFA) for the larger hepatocellular carcinomas. Methods CT-guided RFA was performed in 27 patients with larger hepatocellular carcinoma (total of 31 lesions), who showed poor response to transcatheter arterial chemoembolization (TACE) treatment. The diameter of the lesions was 5.4-11 cm, with a mean diameter of 6.2 cm. Positive AFP was detected in 22 patients. The therapeutic efficacy was evaluated with enhanced CT scanning and AFP. All patients were followed up for 2 - 20 months. Results Follow-up checkups were carried out one month after RFA treatment. Of 31 lesions, complete necrosis was demostrated in 14 (45.2%) and partial necrosis in 17 (54.8%). On enhanced CT scans, no obvious enhancement in the center or at the margin of the complete necrotic lesions was seen. Of 22 patients with positive AFP, the AFP level was markedly reduced in 15 (68.2%), unchanged in 3 (13.6%) and elevated in 4 (18.2%).Complications occurred in 7 patients, including epidermal scald (n = 3), refractory hiccup (n = 1 ), intra- hepatic hemorrhage (n = 1), hepatic abscess (n = 1) and severe hypoproteinemia (n = 1, died 2 months after RFA). The median survival period was 9.8 months and the one-year cumulative survival rate was 29%. Conclusion RFA is an effective treatment for unresectable and larger hepatocellular carcinomas. When this local interventional therapy is employed properly, it can obviously improve the patients' living quality and prolong their surviving span.
出处 《介入放射学杂志》 CSCD 北大核心 2009年第5期353-356,共4页 Journal of Interventional Radiology
关键词 射频消融 肝癌 CT引导 radiofrequency ablation hepatocellular carcinoma CT-guidance
  • 相关文献

参考文献8

二级参考文献32

  • 1崔彦,周立艳,王平,董满库,吉敏,李晓鸥,刘子沛,陈昌玮,张宏文,许永杰.超声引导经皮射频治疗肝脏良恶性肿瘤[J].中华肝胆外科杂志,2004,10(1):20-22. 被引量:9
  • 2崔彦,周立艳,吉敏,李晓鸥,董满库,王平,陈昌玮,刘子沛,许永杰.经皮射频治疗肝脏恶性肿瘤114例临床分析[J].中国现代医学杂志,2004,14(20):129-131. 被引量:13
  • 3陈敏山,李锦清,梁惠宏,林小军,郭荣平,郑云,张亚奇.经皮射频消融与手术切除治疗小肝癌的疗效比较[J].中华医学杂志,2005,85(2):80-83. 被引量:144
  • 4刘增荣,吴晗,贺俊花,李向东,宗广胜,董毅,林剑平,罗秀珍.介入治疗巨大超巨大肝癌71例分析[J].现代医用影像学,2003,12(4):148-149. 被引量:2
  • 5吴宇旋,窦永充,张彦舫,沈新颖,郑雪芬,孙国平,徐坚民.经皮射频消融治疗膈下肝癌[J].介入放射学杂志,2006,15(12):728-731. 被引量:16
  • 6Livraghi T, Goldberg SN, Lazzaroni S, et al. Hepatocellular carcinoma: radio-frequency ablation of medium and large lesions. Radiology, 2000,214:761-768.
  • 7Arii S, Yamaoka Y, Futagawa S, et al. Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrosPective and nationwide survey in Japan. The Liver Cancer Study Group of Japan. Hepatology, 2000,32: 1224-1229.
  • 8Lau WY, Leung TW, Yu SC, et al. Percutaneous local ablative therapy for hepatocellular carcinoma:a review and look into the future. Ann Surg, 2003,237: 171-179.
  • 9Orlando A, D'Antoni A, Camma C, et al. Treatment of small hepatocellular carcinoma with percutaneous ethanol injection: a validated prognostic model. Am J Gastroenterol. 2000, 95: 2921-2927.
  • 10Livraghi T, Goldberg SN, Lazzaroni S, et al. Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injection. Radiology, 1999,210: 655-661.

共引文献941

同被引文献120

引证文献10

二级引证文献90

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部